Spartan Fund Management’s Climate Real Impact Solutions II Acquisition Corporation Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant CLIM.U Stock Holding History
Bought
Maintained
Sold
Other funds holding CLIM.U
LIM
TAL
SIM
WCMNY
HF
KC
Spartan Fund Management's CLIM.U Position: Q3 2022 in Review
Spartan Fund Management sold out of Climate Real Impact Solutions II Acquisition Corporation Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant (CLIM.U) in Q3 2022, closing a stake of 163,377 shares — an estimated $1.61M sold.
Spartan Fund Management first reported a position in CLIM.U in Q1 2022 and held it in 2 quarters. The position peaked at $2.01M in Q1 2022. 19 funds tracked by Wall St. Rank hold CLIM.U as of Q3 2022.
- Spartan Fund Management reported no remaining Climate Real Impact Solutions II Acquisition Corporation Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant position as of Q3 2022 after selling out during the quarter.
- Spartan Fund Management sold 163,377 Climate Real Impact Solutions II Acquisition Corporation Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant shares in Q3 2022, an estimated $1.61M.
- Spartan Fund Management first reported a position in Climate Real Impact Solutions II Acquisition Corporation Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant in Q1 2022 and held it in 2 quarters.
- Spartan Fund Management's Climate Real Impact Solutions II Acquisition Corporation Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant position peaked at $2.01M in Q1 2022.
- 19 funds tracked by Wall St. Rank held Climate Real Impact Solutions II Acquisition Corporation Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant as of Q3 2022.
Based on Spartan Fund Management's 13F filing for Q3 2022, filed 26 Oct 2022.